Toggle Dropdown
Announcements
Projects
Welcome guest
Log in
Loading
Loading...
https://www.ft.com/content/a204a830-4c54-4832-94d8-62b040e6fd48
0
0
Novo Nordisk's obesity drug cuts risk of death by 18%, trial data shows - Financial Times
11/11/23 at 1:30pm
Organization
Financial Times
Author
Hannah Kuchler
Details
32 words
Summarize
Health Conditions
Novo Nordisk
obesity drug cuts risk
Financial Times Wegovy
Wegovy found to have ‘quite profound’ effect on reducing risk of heart attacks, says pharma group
Show more
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...